Abnormality in plasma catecholamines and myocardial adrenoceptors in cardiomyopathic BIO 53.58 Syrian hamsters and improvement by metoprolol treatment

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 3, 1997, Pages 1389-1395

  Yamada, Shizuo ^a   Ohkura, Takashi ^a   Yamadera, Tooru ^a   Ito, Osamu ^a   Kimura, Ryohei ^a   Nozawa, Yoshihisa ^b   Hayashi, Shuji ^b   Miyake, Hidekazu ^b  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ANGIOTENSIN 2 RECEPTOR; CATECHOLAMINE; METOPROLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CATECHOLAMINE BLOOD LEVEL; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SYRIAN HAMSTER;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CARDIOMYOPATHY, DILATED; CATECHOLAMINES; CRICETINAE; MALE; MESOCRICETUS; METOPROLOL; MYOCARDIUM; RECEPTORS, ADRENERGIC; RECEPTORS, ANGIOTENSIN;

EID: 0031456082     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. BÖHM, M., BEUCKELMANN, D., BROWN, L., FEILER, G., LORENZ, B., NABAUER, M., KEMKES, B. AND ERDMANN, E.: Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur. Heart J. 9: 844-852, 1988.
2. BRISTOW, M. R., GINSBURG, R., MINOBE, W., CUBICCIOTTI, R. S., SAGEMAN, W. S., LURIE, K., BILLINGHAN, M. E., HARRISON, D. C. AND STINSON, E. B.: Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N. Engl. J. Med. 307: 205-211, 1982.
3. 2-adrenoceptors in the human heart: Properties, function, and alterations in chronic heart failure. Pharmacol. Rev. 43: 203-241, 1991.
4. BRODDE, O. E., KRETSCH, R., IKEZONO, K., ZERKOWSKI, H. R. AND REIDEMEISTER, J. C.: Human β-adrenoceptors: Relation of myocardial and lymphocyte β-adrenoceptor density. Science (Wash. DC) 231: 1584-1585, 1986.
5. 2-adrenoceptors. Eur. Heart J. 10: suppl B, 38-44, 1989.
6. CHIDSEY, C. A., HARRISON, D. C., BRAUNWALD, E.: Augmentation of the plasma norepinephrine response to exercise in patients with congestive heart failure. N. Eng. J. Med. 267: 650-654, 1962.
7. CRUICKSHANK, J. M., NEIL-DWYER, G., CAMERON, M. M. AND MCAINSH, J.: β-adrenoceptor-blocking agents and the blood-brain barrier. Clin. Sci. 59: 453s-455s, 1980.
8. DIMANES, E., KERR, D. AND MACDONALD, I.: Beta-adrenoceptor blockade and CNS-related subjective symptoms: Randomized, double-blind, placebo-controlled propranolol LA in healthy subjects. J. Clin. Pharmacol. 30: S103-S107, 1990.
9. FELDMAN, A. M., TENA, R. G., KESSLER, P. D., WEISMAN, H. F., SCHULMAN, S. P., BLUMENTHAL, R. S., JACKSON, D. G. AND DOP, C. V.: Diminished β-adrenergic receptor responsiveness and cardiac dilation in hearts of myopathic Syrian hamsters (BIO 53.58) are associated with a functional abnormality of the G stimulatory protein. Circulation 81: 1341-1352, 1990.
10. FOWLER, M. B. AND BRISTOW, M. R.: Rationale for freta-adrenergic blocking drugs in cardiomyopathy. Am. J. Cardiol. 55: 120D-124D, 1985.
11. FOWLER, M. B., LASER, J. A., HOPKINS, G. L., MINOBE, W. AND BRISTOW, M. R.: Assessment of the β-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response. Circulation 74: 1290-1302, 1986.
12. FRANCIS, G. S., GOLDSMITH, S. R., ZIESCHE, S. M. AND COHN, J. N.: Response of plasma norepinephrine and epinephrine to dynamic exercise in patients with congestive heart failure. Am. J. Cardiol. 49: 1152-1156, 1982.
13. GERTZ, E. W.: Cardiomyopathic Syrian hamster: A possible model of human disease. Prog. Exp. Tumor Res. 16: 242-260, 1972.
14. HANSSON, C., AGRUP, G., RORSMAN, H., ROSENGREN, A. -M. AND ROSENGREN, E.: Analysis of cysteinyldopas, dopa, dopamine, noradrenaline and adrenaline in serum and urine using high-performance liquid chromatography and electrochemical detection. J. Chromatogr. 162: 7-22, 1979.
15. HEGSTRAND, L. R. AND EICHELMAN, B.: Determination of rat brain tissue catecholamines using liquid chromatography with electrochemical detection. J. Chromatogr. 222: 107-111, 1981.
16. HEILBRUNN, S. M., SHAH, P., BRISTOW, M. R., VALANTINE, H. A., GINSEURG, R. AND FOWLER, M. B.: Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 79: 483-490, 1989.
17. ISHIDA, S., MAKINO, N., MASUTOMO, K., HATA, T. AND YANAGA, T.: Effect of metoprolol on the β-adrenoceptor density of lymphocytes in patients with dilated cardiomyopathy. Am. Heart J. 125: 1311-1315, 1993.
18. KAILA, T. AND MARTTILA, R.: Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS. Br. J. Clin. Pharmacol. 35: 507-515, 1993.
19. KAWAGUCHI, H., SHOKI, M., SANO, H., KUDO, T., SAWA, H., OKAMOTO, H., SAKATA, Y. AND YASUDA, H.: Phospholipid metabolism in cardiomyopathic hamster heart cells. Circ. Res. 69: 1015-1021, 1991.
20. KAWAGUCHI, H., SHOKI, M., SANO, H., KUDO, T., SAWA, H., OKAMOTO, H., SAKATA, Y. AND YASUDA, H.: The studies of cell damaging and cell growth factors which induce cardiomyopathy. Jpn. Circ. J. 56: 1037-1044, 1992.
21. KESSLER, P. D., CATES, A. E., VAN DOP, C. AND FELDMAN, A. M.: Decreased bioactivity of the guanine nucleotide-binding protein that stimulates adenylate cyclase (Gs) in hearts from cardiomyopathic Syrian hamsters. J. Clin. Invest. 84: 244-252, 1989.
22. LANGER, S. Z.: Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23: 1793-1800, 1974.
23. LEVINE, T. B., FRANCIS, G. S., GOLDSMITH, S. R., SIMON, A. B. AND COHN, J. N.: Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am. J. Cardiol. 49: 1659-1666, 1982.
24. LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
25. NEIL-DWYER, G., BARTLETT, J., MCAINSH, J. AND CRUICKSHANK, J. M.: β-adrenoceptor blockers and the blood-brain barrier. Br. J. Clin. Pharmacol. 11: 549-553, 1981.
26. NOZAWA, Y., HARUNO, A., ODA, N., YAMASAKI, Y., MATSUURA, N., YAMADA, S., INABE, K., KIMURA, R., SUZUKI, H. AND HOSHINO, T.: Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J. Pharmacol. Exp. Ther. 270: 566-571, 1994.
27. ROSENTHAL, H. E.: Graphic method for the determination and presentation of binding parameters in a complex system. Anal. Biochem. 20: 525-532, 1967.
28. 2-adrenoceptors in different human heart disease. Arch. Pharmacol. 343: 217-220, 1991.
29. TAWARAHARA, K., KURATA, C., TAGUCHI, T., KOBAYASHI, A. AND YAMAZAKI, N.: Augmentation of adrenergic receptors in cardiomyopathic hamsters (BIO 14.6) with heart failure. Cardiovasc. Res. 26: 526-533, 1992.
30. TAYLOR, R. B., REID, R., KENDLE, K. E., GEDDES, C. AND CURLE, P. F.: Assay procedures for the determination of biogenic amines and their metabolites in rat hypothalamus using ion-pairing reversed-phase high-performance liquid chromatography. J. Chromatogr. 277: 101-114, 1983.
31. THOMAS, J. A. AND MARKS, B. H.: Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41: 233-243, 1978.
32. TOMITA, T., MURAKAMI, T., IWASE, T., NAGAI, K., FUJITA, J. AND SASAYAMA, S.: Chronic dynamic exercise improves a functional abnormality of the G stimulatory protein in cardiomyopathic BIO 53.58 Syrian hamsters. Circulation 89: 836-845, 1994.
33. VIZI, E. S.: Presynaptic modulation of neurochemical transmission. Prog. Neurobiol. 12: 181-290, 1980.
34. WAAGSTEIN, F., CAIDAHL, K., WALLENTIN, I., BERGH, C. -H., AND HJALMARSON, A.: Long-term β-blockade in dilated cardiomyopathy. Circulation 80: 551-563, 1989.
35. WAAGSTEIN, F., HJALMARSON, A., SWEDBERG, K. AND WALLENTIN, I.: Beta-blockers in dilated cardiomyopathy: They work. Eur. Heart J. 4: 173-178, 1983.
36. WAGNER, J. A., REYNOLDS, I. J., WEISMAN, H. F., DUDECK, P., WEISFELDT, M. L. AND SNYDER, S. H.: Calcium antagonist receptors in cardiomyopathic hamsters: Selective increase in heart, muscle, brain. Science (Wash. DC) 232: 515-518, 1986.
37. WAGNER, J. A., WEISMAN, H. F., SNOWMAN, A. M., REYNOLDS, I. J., WEISFELDT, M. L. AND SNYDER, S. H.: Alterations in calcium antagonist receptors and sodium-calcium exchange in cardiomyopathic hamster tissues. Cir. Res. 65: 205-214, 1989.
38. 1-adrenergic receptors. Biol. Pharm. Bull. 16: 660-663, 1993.
39. WHITMER, J. T.: L-Carnitine treatment improves cardiac performance and restores high-energy phosphate pools in cardiomyopathic Syrian hamsters. Cir. Res. 61: 396-408, 1987.
40. WHITMER, J. T., KUMAR, P. AND SOLARO, R. J.: Calcium transport properties of cardiac sarcoplasmic reticulum from cardiomyopathic Syrian hamsters (BIO 53.58 and 14.6): Evidence for a quantitative defect in dilated myopathic hearts not evident in hypertrophic hearts. Cir. Res. 62: 81-85, 1988.
41. YAMADA, S., OHKURA, T., UCHIDA, S., INABE, K., IWATANI, Y., KIMURA, R., HOSHINO, T. AND KABURAGI, T.: A sustained increase in β-adrenoceptors during long-term therapy with metoprolol and bisoprolol in patients with heart failure from idiopathic dilated cardiomyopathy. Life Sci. 58: 1737-1744, 1996.
42. 1-adrenoceptor antagonists to prostatic α-adrenoceptors in benign prostatic hypertrophy. Life Sci. 50: 127-135, 1992.
43. 3H]WB4101: Effect of 6-hydroxydopamine treatment. J. Pharmacol. Exp. Ther. 215:176-185, 1980a.
44. YAMADA, S., YAMAMURA, H. I. AND ROESKE, W. R.: Alteration in cardiac autonomic receptors following 6-hydroxydopamine treatment in rats. Mol. Pharmacol. 18: 185-192, 1980b.